SCHEMBL8961773

SCHEMBL8961773

CCCCCCCCCCOc1ccc(-c2ncc(CCCCCCCCCC)cn2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.63
RAB9A P51151 5/20 0.63
KDM4E B2RXH2 4/20 0.63
NPC1 O15118 3/20 0.63
SMN1; SMN2 Q16637 3/20 0.63
HSD17B10 Q99714 2/20 0.63
ALDH1A1 P00352 4/20 0.60
MAPT P10636 3/20 0.60
HPGD P15428 3/20 0.60
MEN1 O00255 2/20 0.60
USP2 O75604 2/20 0.60
KMT2A Q03164 2/20 0.60
GAA P10253 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.56
CASP3 P42574 1/20 0.52
SENP8 Q96LD8 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
CYP3A4 P08684 2/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9436035 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL9636338 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL7907379 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL13029249 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL10342131 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL9241350 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL7910730 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL7121080 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL4815333 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL2774683 1.00 RARB (0.63) RARBRAB9AKDM4ENPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8821992-B2 Oligosiloxane modified liquid crystal formulations and devices using same DOW CORNING CORPORATION (US) 2014-09-02 US disclosed
US-8368831-B2 Oligosiloxane modified liquid crystal formulations and devices using same DOW CORNING CORPORATION (US) 2013-02-05 US disclosed
US-20100283925-A1 OLIGOSILOXANE MODIFIED LIQUID CRYSTAL FORMULATIONS AND DEVICES USING SAME DOW CORNING CORPORATION (US) 2010-11-11 US disclosed
US-20100283927-A1 OLIGOSILOXANE MODIFIED LIQUID CRYSTAL FORMULATIONS AND DEVICES USING SAME DOW CORNING CORPORATION (US) 2010-11-11 US disclosed
US-5518653-A LIQUID CRYSTAL HOFFMANN-LA ROCHE INC. (US) 1996-05-21 US disclosed
EP-0523543-B1 Chiral piperazine derivatives HOFFMANN LA ROCHE (CH) 1996-02-07 EP disclosed
EP-0457105-B1 Chiral dioxanes as components of liquid crystal mixtures HOFFMANN LA ROCHE (CH) 1995-07-26 EP disclosed
US-5356563-A Two plate electrooptical cell HOFFMANN-LA ROCHE INC. (US) 1994-10-18 US disclosed
US-5356559-A Optically active piperazinyl derivatives as liquid crystals HOFFMANN-LA ROCHE INC. (US) 1994-10-18 US disclosed
EP-0247466-B1 Liquid-crystal derivatives of phenyl benzoate HOFFMANN LA ROCHE (CH) 1993-11-24 EP disclosed
US-5244597-A Liquid crystalline mixtures having a chiral tilted smectic phase HOFFMANN-LA ROCHE INC. (US) 1993-09-14 US disclosed
EP-0343487-B1 CYCLOHEXYL ESTERS OF ALPHA-FLUORO/CARBOXYLIC ACIDS F. HOFFMANN-LA ROCHE AG (CH) 1993-01-20 EP disclosed
US-5082589-A Liquid crystalline esters HOFFMANN-LA ROCHE INC. (US) 1992-01-21 US disclosed
EP-0457105-A1 Chiral dioxanes as components of liquid crystal mixtures F. HOFFMANN-LA ROCHE AG (CH) 1991-11-21 EP disclosed
US-4925278-A Liquid crystalline esters HOFFMANN-LA ROCHE INC. (US) 1990-05-15 US disclosed
US-4906401-A Use of liquid-crystal 5-phenylpyrimidine derivatives as components of smectic liquid-crystal mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1990-03-06 US disclosed
EP-0343487-A1 Cyclohexyl esters of alpha-fluoro/carboxylic acids F. HOFFMANN-LA ROCHE AG (CH) 1989-11-29 EP disclosed
US-4830470-A Liquid crystalline esters HOFFMANN-LA ROCHE INC. (US) 1989-05-16 US disclosed
EP-0284008-A2 Use of derivatives of 5-phenyl pyrimidine as components of smectic liquid-crystalline mixtures HOECHST AKTIENGESELLSCHAFT (DE) 1988-09-28 EP disclosed
EP-0247466-A2 Liquid-crystal derivatives of phenyl benzoate F. HOFFMANN-LA ROCHE AG (CH) 1987-12-02 EP disclosed